Nucleai
AI-Driven Spatial Biomarkers
- Headquarters
- Tel Aviv
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- nucleai.ai
About
AI-powered spatial biology platform using computer vision to analyze tissue architecture and identify cancer biomarkers.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSimilar Companies
Devoted Health
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Waltham, United States1001–5000Artificial Intelligence, Healthcare
Extension Round·$3.5B·Aug 2024
Isomorphic Labs
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
inVentiv HealthAcquired
Biopharmaceutical services company
United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004

AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Hugel
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Chuncheon, South Korea201–500Aesthetics, Biotech
Private Equity·$2.3B·Aug 2021